These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30044350)

  • 1. Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.
    Metcalf RA; Khan J; Andrews J; Mayock D; Billimoria Z; Pagano MB
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):632-634. PubMed ID: 30044350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO hemolytic disease.
    Cook LN
    Clin Obstet Gynecol; 1982 Jun; 25(2):333-9. PubMed ID: 7105509
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
    Drabik-Clary K; Reddy VV; Benjamin WH; Boctor FN
    Ann Clin Lab Sci; 2006; 36(2):205-7. PubMed ID: 16682519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.
    Awad HA; Tantawy AA; El-Farrash RA; Ismail EA; Youssif NM
    Blood Transfus; 2014 Apr; 12(2):250-9. PubMed ID: 24333075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Hemolytic Disease of a Newborn with Bilirubin of 37.3 mg/dL and High anti-A Titer: Corrected with Reconstituted Whole Blood Exchange.
    Ye Z; Wadsworth M; Wolf L; Jones S; Cotten K; Dasgupta A
    Ann Clin Lab Sci; 2024 May; 54(3):413-415. PubMed ID: 39048171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
    Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
    Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO Hemolytic Disease of Newborn in the antenatal O group mothers and their neonatal outcome in a tertiary care hospital in Northern India.
    Deb J; Jain A; Kaur D; Bahadur A; Basu S; Negi G
    Transfus Apher Sci; 2024 Feb; 63(1):103864. PubMed ID: 38135544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mercaptoethanol-stable antibody test predicting hemolytic disease of the newborn due to ABO incompatibility.
    Hasekura H
    Vox Sang; 1974; 26(5):439-48. PubMed ID: 4842479
    [No Abstract]   [Full Text] [Related]  

  • 12. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis.
    Li P; Pang LH; Liang HF; Chen HY; Fan XJ
    Fetal Pediatr Pathol; 2015; 34(6):341-50. PubMed ID: 26359685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Causes of regression in the exchange transfusion of newborn infants in Styria].
    Rosegger VH; Teubl I; Stern E; Müller WD; Haidvogl M
    Wien Med Wochenschr; 1978 May; 128(10):298-301. PubMed ID: 96610
    [No Abstract]   [Full Text] [Related]  

  • 15. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO hemolytic disease of the newborn: a need for clarity and consistency in diagnosis.
    Watchko JF
    J Perinatol; 2023 Feb; 43(2):242-247. PubMed ID: 36344813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease.
    Das S; Shastry S; Chakravarthy PK; Baliga PB
    Transfus Med; 2021 Feb; 31(1):30-35. PubMed ID: 32969542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of high risk pregnancies with relation to ABO haemolytic disease of newborn.
    Usha KK; Sulochana PV
    Indian J Pediatr; 1998; 65(6):863-5. PubMed ID: 10773951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of immunohematologic testing in mother and newborn ABO incompatibility.
    Novoselac J; Buzina Marić K; Rimac V; Selak I; Raos M; Golubić Ćepulić B
    Immunohematology; 2023 Jun; 39(2):55-60. PubMed ID: 37405847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.